Urology

The UroLift System is a new, minimally invasive approach. It treats Benign Prostatic Hyperplasia (BPH) and is an alternative to drug therapy or more invasive surgery. This is a straightforward procedure that utilizes tiny implants to lift and hold the enlarged prostate tissue out of the way so it no longer blocks the urethra. There is no cutting, heating or removal of prostate tissue.

Clinical data has proven that the UroLift System treatment is safe and effective and can improve BPH symptoms three to four times greater than with medication¹. Results have shown durability to two years with no impact to sexual function². The goal is to relieve you of bothersome urinary symptoms so you can get back to your life and resume daily activities.

Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure¹.

1. Roehrborn, Can J Urol 2015, 3-Year L.I.F.T. Study
2. Roehrborn, Urology Practice 2015, 2-Year L.I.F.T. Study
3. Roehrborn, J Urol 2013, L.I.F.T. Study

Visit the official UroLift website for more information about how the system works.

Benign Prostatic Hyperplasia (BPH) is a condition in which the prostate enlarges‚ as men get older‚ Over 70 percent of men in their 60s have BPH symptoms. While BPH is a benign condition and unrelated to prostate cancer, it can greatly affect a man’s quality of life.